People, practice and progress across European aesthetics
Independent, source-led reporting
Clear professional intelligence, built around verified evidence
Source-led reporting on health, professional practice and public-interest developments across European aesthetics.
Public Health
Faster care access announced for motor neurone disease patients
People living with motor neurone disease are set to receive faster access to specialist care and support under measures announced by the Department of Health and Social Care. The change is intended to reduce delays after diagnosis and make it easier for patients and families to reach the services they need.
MHRA clarifies licensing rules for microbiome-based medicines in the UK
The Medicines and Healthcare products Regulatory Agency published its UK position on microbiome-based medicinal products on 18 August 2026. The document explains the licensing route and gives developers a clearer basis for working within the existing medicines framework.
NHS England marks milestone of treating over 100,000 hepatitis C patients
NHS England has reported that more than 100,000 people received treatment for hepatitis C between 2015 and August 2026. The milestone reflects a decade of work to find people living with the virus and provide curative treatment.